Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib + Sirolimus in Refractory Sarcomas/MPNST
NCT02008877Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Dec 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in malignant peripheral nerve sheath tumor (MPNST), sarcoma, sponsored by Sarcoma Alliance for Research through Collaboration. Started Dec 2013; status: completed.
02
Drugs
ganetespib
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)sarcoma
Beyond the preview
Go deeper on NCT02008877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008877.